Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Granule and Powder Flowability Testing – V 2.0

Posted on By

Tablets: SOP for Granule and Powder Flowability Testing – V 2.0

Standard Operating Procedure for Granule and Powder Flowability Testing

Department Quality Control
SOP No. SOP/TAB/118/2025
Supersedes SOP/TAB/118/2022
Page No. Page 1 of 6
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

To define the procedure for testing the flowability of granules and powder used in tablet formulations, ensuring optimal flow characteristics for processing and uniformity in tablet manufacturing.

2. Scope

This SOP applies to the testing of granules and powders used in tablet manufacturing to ensure they meet the required flowability specifications, essential for proper mixing, compression, and uniformity.

3. Responsibilities

  • Quality Control (QC): Responsible for performing the granule and powder flowability testing and ensuring that the results meet the specifications.
  • Quality Assurance (QA): Ensures that the testing is performed according to this SOP and reviews the results to confirm compliance with product specifications and regulatory standards.
  • Laboratory Personnel: Responsible for preparing the samples, conducting the flowability testing, and recording the results accurately.

4. Accountability

The QC Manager is accountable for ensuring that flowability testing is performed accurately and consistently. The QA Manager is responsible for reviewing and approving the test results to ensure that the product complies with internal and regulatory standards.

See also  Tablets: SOP for Validating Computerized Systems in QA - V 2.0

5. Procedure

5.1 Sample Preparation

  1. Weigh a representative sample of the granules or powder (e.g., 50 g to 100 g) from the batch to be tested.
  2. Ensure that the sample is free from moisture and foreign materials, as these factors can affect the flowability of the powder or granules.
  3. Ensure that the granules or powder are at room temperature before testing to avoid any variability in flowability due to temperature changes.

5.2 Flowability Testing Methods

The following methods can be used for testing granule and powder flowability:

  1. Angle of Repose Method:
    • Place the granules or powder into a funnel and allow them to fall freely onto a flat surface.
    • Measure the height and diameter of the formed powder cone.
    • Calculate the angle of repose using the formula:
      • tan(θ) = h / r
      • Where:
        θ = angle of repose, h = height of the powder cone, r = radius of the powder cone base.
  2. Flow Rate Method:
    • Use a standardized powder funnel (e.g., powder flow function funnel) to measure the rate at which the powder flows through the orifice under standardized conditions.
    • Record the time taken for a specific amount of powder to flow through the funnel.
  3. Powder Flow Tester (Carr’s Index):
    • Determine the bulk density and tapped density of the granules or powder.
    • Calculate the Carr’s Index using the following formula:
      • Carr’s Index (%) = [(Tapped Density – Bulk Density) / Tapped Density] × 100
    • Evaluate the flowability based on the Carr’s Index:
      • 0–10%: Excellent Flow
      • 11–15%: Good Flow
      • 16–20%: Fair Flow
      • 21–25%: Passable Flow
      • Above 25%: Poor Flow
See also  Tablets: SOP for Adhesion Testing of Coated Tablets During Production - V 2.0

5.3 Recording Results

  1. Record all measurements, including the angle of repose, flow rate, Carr’s Index, and other relevant data in the batch record (Annexure-2).
  2. Ensure that all results are signed, dated, and stored according to the company’s record retention policy.
  3. If any result falls outside of the acceptance criteria, investigate and document corrective actions in the deviation report (Annexure-1).

5.4 Acceptance Criteria

  1. For Angle of Repose: The angle should not exceed 40 degrees. Higher values indicate poor flowability.
  2. For Flow Rate Method: The time taken for the powder to flow should meet the predefined specification. Any deviation must be documented.
  3. For Carr’s Index: The Carr’s Index should be below 25% for satisfactory flowability. A value above 25% indicates poor flow and requires further investigation.

5.5 Documentation and Record-Keeping

  1. Document all flowability test results, including any deviations, corrective actions, and re-tests, in the batch record (Annexure-2).
  2. Ensure that all records are signed, dated, and stored according to the company’s record retention policy for future audits and inspections.
  3. Maintain raw data, including time measurements, funnel measurements, and any deviation reports, for regulatory compliance and future reference.

5.6 Post-Test Actions

  1. Clean all equipment used for granule and powder flowability testing to remove any residual material and prevent cross-contamination.
  2. Dispose of used samples and solvents according to the company’s waste disposal procedures.
  3. Ensure that any equipment used for flowability testing, such as the funnel, powder tester, or micrometer, is regularly calibrated and maintained according to the manufacturer’s guidelines.
See also  Tablets: SOP for Cleaning Validation Swab Analysis in Quality Control - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • API: Active Pharmaceutical Ingredient
  • Carr’s Index: A measure of the powder’s flowability
  • HPLC: High-Performance Liquid Chromatography

7. Documents

  1. Batch Record (Annexure-2)
  2. Deviation Report (Annexure-1)

8. References

  • USP <616> – Powder Flowability Testing
  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • European Pharmacopoeia (EP) – Specifications for Powder Flowability

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
15/12/2025 Batch 001 Inconsistent particle size in coating Adjusted homogenizer settings and re-tested John Doe

Annexure-2: Batch Record

Batch Number Sample Weight (g) Homogenization Pressure (bar) Particle Size (µm) Coating Thickness (µm) Result
Batch 001 100 g 1500 bar 150 µm 25 µm Pass

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated homogenization pressure limits Improved testing conditions QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: Capsule: SOP for API and Excipient Compatibility Studies – V 2.0
Next Post: Creams: SOP for Preventing Contamination during Material Dispensing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version